SUVEN LIFE SCIENCES
Back to Cashflow Statement
|
SUVEN LIFE SCIENCES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.05 Cr | ₹396 Cr | ₹146 Cr | ₹35 Cr | ₹2.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN LIFE SCIENCES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1.05 Cr |
Mar2023 | ₹396 Cr |
Mar2022 | ₹146 Cr |
Mar2021 | ₹35 Cr |
Mar2020 | ₹2.81 Cr |
How is Cash Flow from Financing Activities of SUVEN LIFE SCIENCES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1.05 Cr | Negative | |
Mar2023 | ₹396 Cr | 171.49 | |
Mar2022 | ₹146 Cr | 317.98 | |
Mar2021 | ₹35 Cr | 1,142.20 | |
Mar2020 | ₹2.81 Cr | - |
Compare Cash Flow from Financing Activities of peers of SUVEN LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN LIFE SCIENCES | ₹6,391.4 Cr | 9% | 23.6% | 124.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 2.3% | 3.2% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -0.2% | 4.5% | 49.6% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.2% | -2% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 3.7% | 6.5% | 16.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0% | -4.6% | -6.2% | Stock Analytics |
SUVEN LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN LIFE SCIENCES | 9% |
23.6% |
124.4% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses